ODAC votes 8-5 on Gliadel benefit

The FDA's Oncologic Drugs Advisory Committee voted 8-5 that GLFD's Gliadel Wafer carmustine implant provides clinical benefit with an acceptable safety profile in treating patients with newly diagnose...